
Sou #cirurgiao #oncologista dedicado ao #tratamento dos #tumores abdomino-pélvicos, em especial ao #cancer de #ovario
Recife, PE, Brazil
Joined March 2020
- Tweets8.6K
- Following1.3K
- Followers1.3K
- Likes17.4K
Thales P. Batista, MD, PhD retweeted
IO does not benefit in stage I "high risk" dMMR endo ca. And considering prior RCTs have not shown a PFS or OS benefit to anyt form of RT (the "control" arm), I dont see a value to any postop therapy in these surgcially staged case at all. Enjoy
onclive.com/view/nrg-gy020-p…
Thales P. Batista, MD, PhD retweeted
And full LND also done and over for even SLN positive cervical cancer based on PHENIX II. #IGCS2026 time for our field to stop full LND for clinically normal nodes in all cervix and endometrial cancer. SLN algorithm is all we need.
Thales P. Batista, MD, PhD retweeted
Medicine is a distinct & elite profession & I’m getting tired of people trying pretend that there’s a shortcut to the years of hard work it takes to become a doctor
Tiered rotas are nothing more than gaslighting patients into worse care
I’m glad it’s being called out publicly
Thales P. Batista, MD, PhD retweeted
3 Practical Recommendations to Improve Survival Outcome Reporting and Transparency in Gynecologic Oncology - Giuseppe Caruso(@gcarusomd)
@BatistaTP
oncodaily.com/voices/giusepp…
#OncoDaily #Oncology #Cancer #Health #Medicine #GynecologicOncology #MedX #MedTwitter
Thales P. Batista, MD, PhD retweeted
#LeadArticle Long-term survival outcomes in high-risk #EndometrialCancer patients undergoing SLN biopsy alone vs lymphadenectomy @frafanfani
📌 bit.ly/3pxCAI3
@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @OncoAlert @IJGCfellows
Thales P. Batista, MD, PhD retweeted
Dr Jason Wright from @greenjrnl encouraging people to keep trying to get your paper published even if initially rejected. Don’t perseverate, consider the peer reviewer comments, just revise and re-submit! @IGCSociety #igcs2025
Thales P. Batista, MD, PhD retweeted
The🇨🇳#RCT named #PHENIX promises to be definitive for #SLB in #CervicalCancer. Its time for painting the surgical field of #Green! #FGS #ICG #EasyLight @isfgs @IJGConline @DrFMartinelli @pedroramirezMD @HsuMd @arthurfkrause @sbco_oficial @agz_eriksson
ijgc.bmj.com/content/30/11/1…
Thales P. Batista, MD, PhD retweeted
A SBCO marcou presença no @ESSOnews na Suécia! 🇸🇪
A presença da SBCO destacou a importância de ver o Brasil cada vez mais representado nas discussões internacionais e na construção de políticas públicas voltadas ao tratamento oncológico.
#SBCO #ESSO2025 #CirurgiaOncológica
Thales P. Batista, MD, PhD retweeted
Proud to share this amazing paper from @CliniTransplant by @WileyGlobal , an official journal of the @AST_info & @ASTSChimera.#Transplantation #KidneyTransplant #Surgery #Urology @eLightICG 🧵1/n
🔗onlinelibrary.wiley.com/doi/…
Thales P. Batista, MD, PhD retweeted
We’re thrilled to announce Dr. Mario Leitao as one of two recipients selected for the 2025 IGCS Excellence in Teaching Award! 👏
As Fellowship Director at Memorial Sloan Kettering Cancer Center and Professor at Weill Cornell, Dr. Leitao trains one of the largest cohorts of gynecologic oncology fellows in the world—with a total of 14 clinical fellows at any time and 3 research fellows yearly. The fellowship training also lasts 4 years, which is the longest surgical fellowship at our institution.
He’s performed live surgeries, lectured internationally, pioneered minimally invasive and robotic surgical techniques, and authored over 270 peer-reviewed publications—all while mentoring the next generation of surgical leaders.
His dedication to global education and surgical excellence embodies what this award is all about.
Join us in congratulating Dr. Leitao!
Learn more about his contributions: igcs.org/awards/mario-m-leit…
Thales P. Batista, MD, PhD retweeted
Ovarian Cancer. Common mutually exclusive statements:.
1- Statement: I do not believe in multicentricity, but bilateral ovarian tumors are stage I.
Comment: Ovarian tumors that involve a few millimeters of periovarian soft tissue are considered stage II, but if they also involve the opposite ovary, they are stage I.
This means that they are independent primaries=multicentric.
2- Statement: I do not believe in the hormonal theory of ovarian cancer.
Comment: But you use antihormones in some cases.
Response: Yes, because they work.
Thales P. Batista, MD, PhD retweeted
#IJGCconversations Lymphadenectomy in Low-Grade #OvarianCancer with Elizabeth Tubridy and Dimitrios Nasioudis @DNasioudis
🎙️ bit.ly/44Gtz1f
@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @HelenaObermair @sofiabigardiGMD @marina_rosanu @ChakraRim @FilippoCapom @mcgouveia_
Thales P. Batista, MD, PhD retweeted
The next IJGC Editor-in-Chief could be you!🫵
🔬 Shape the future of #gynecologiconcology
📢 Amplify the journal's global impact
Apply now! bit.ly/3IawupS
@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @HelenaObermair @sofiabigardiGMD @marina_rosanu @ChakraRim @FilippoCapom @mcgouveia_
Thales P. Batista, MD, PhD retweeted
Join us #IJGCclub
📆03/07/2025
⏰11am CDT/6pm CET
Mark your calendars 📅 for an exciting #IJGCclub 💥
Rewinding the clock ⏰ on positive #peritonealcytology in #endometrialcancer: does it predict prognosis in low-risk disease? With Diletta Fumagalli @Dilfum and Gretchen E. Glaser
💻 bit.ly/4jfSMEP
#LeadArticle #IJGConline #Research #Prevention #Treatment #Diagnostic #GynCancer #GynOnc #WomenHealth #SoMe #SoMe4GynOnc
@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @HelenaObermair @sofiabigardiGMD @marina_rosanu @ChakraRim @FilippoCapom @mcgouveia_
Thales P. Batista, MD, PhD retweeted
Proud to be part to this important cornerstone to standardize the CRS and HIPEC @HUReinaSofia @IMIBIC @operarelcancer @aecirujanos
30y after @PSugarbaker s orginal 📜, 🆕revised classification of peritonectomy procedures + def of nomenclatures & boundaries-📰 in @BJSAcademy @glehenolivier
🔓 doi.org/10.1093/bjs/znaf112
Congrats @PSOGI_EC @ESGO_society @ISSPP1 panel
Imp👣 for standardizing CRS+ research in PSM
Thales P. Batista, MD, PhD retweeted
Read our last collaborative study using REGECOP Spain. Paclitaxel HIPEC is an effective alternative to Cisplatin HIPEC. @IMIBIC @HUReinaSofia @PSOGI_EC @indepso @GEICOgroup @_SEOM @operarelcancer @myESMO @ESGO_society @aecirujanos
This quoted post is unavailable.
Thales P. Batista, MD, PhD retweeted
Look at my website to know more about surgical oncology and to get a second opinion !! @seoq @ContraCancerEs @rand_spa @JuanluromaMar @ajierros @HcrCordoba arjonasurgicaloncology.com/
Thales P. Batista, MD, PhD retweeted
I want to go back and re-title all our retrospective studies as “real world”. How can I do that?
🔬 New real-world data on #OvarianCancer surgery!
Which works better: 🔪 Primary or 💉Interval Debulking?
🩺 In 929 pts with stage III–IV EOC:
📈 Primary debulking → ⬆️ OS (68.4 vs 52 mo, p = .0004)
📉 BUT no significant difference after adjustment (HR 1.15, p = .12)
💡 Key takeaways:
👩⚕️ Younger, Stage III, BRCA-WT/HRP → 💪 benefit from primary
🧬 BRCA-mut/HRD → 🔄 similar outcomes with either approach ♻️
📌 Personalized surgery is the way forward!
🔗 bit.ly/4k1caVt
@pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @RParejaGineOnco @lchiv4 @annafagottimd @HousseinELHAJJ3 @AinhoaMada @HelenaObermair @sofiabigardiGMD @marina_rosanu @ChakraRim @FilippoCapom @mcgouveia_
#IJGConline #Research #Treatment #Diagnostic #GynCancer #GynOnc #WomenHealth #SoMe #SoMe4GynOnc























